title: A case of peplomycin-induced scleroderma.
authors.forename: Y
authors.initials: Y
authors.lastname: Asano
authors.forename: H
authors.initials: H
authors.lastname: Ihn
authors.forename: J
authors.initials: J
authors.lastname: Shikada
authors.forename: T
authors.initials: T
authors.lastname: Kadono
authors.forename: K
authors.initials: K
authors.lastname: Kikuchi
authors.forename: K
authors.initials: K
authors.lastname: Tamaki
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001761:Bleomycin / Q000009:adverse effects; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D006801:Humans; D008048:Lip Neoplasms / Q000188:drug therapy; D008297:Male; D017663:Peplomycin / Q000009:adverse effects*; D045743:Scleroderma, Diffuse / Q000139:chemically induced*
chemical_list: D000970:Antineoplastic Agents; D001761:Bleomycin; D017663:Peplomycin